Serafina: Hi, I’m Serafina and this is The HealthMakers Show. I’m with my guest, Erik Ibarra, CEO of ORDRS.io, and we’re over at Station Houston. Thank you so much for joining us today.
Serafina: Tell us about ORDRS.
Erik: ORDRS is a API for the direct to consumer lab testing industry. I know that sounds like a ton of words, but realistically, if you’re familiar with these at home test kits, each one of those kits needs to take in your data as a consumer, as a patient, someone providing a blood sample, or a saliva sample and they need to share that with a physician, with a lab. The lab has got to test that kit and then report results back to you as a consumer. We help in that exchange. We’ve built a back end that allows all those stakeholders to seamlessly share that data, securely share that data, ultimately providing you the consumer, meaningful results and an understanding of where you’re at in your health care.
Serafina: This technology sounds really intuitive. It sounds like it’s been needed in the marketplace for a while. Why hasn’t it existed and what is the present-day system?
Erik: We can think of health care as sort of we’ve gone down this path from you have to go to a physician if you’re feeling bad, and then that physician, like your primary care physician will recommend a test, and then you take that test, and then you go back to your physician after the results are available, they tell you what that test means and then they give you some idea of what you can do to improve your health. That is sort of the way that still exists today but is also something that’s existed for decades. Now we’re transitioning into this what we call personalized health phase of health care that involves you being able to, from the comfort of your own home, order a test, it shows up at your door, either it’s a pinprick or sometimes it is a blood collection device that’s near painless, you send that off to the lab, and in about 3-5 days you get results emailed. They email you to let you know your results are available and you login to a secure system, and you’re able to understand those results because they’re well designed and intuitive, but these companies are also putting you in touch with a physician should you have questions about your results.
Serafina: How do you provide the foundation for a patient to make an informed decision around that?
Erik: There are a ton—when we think about healthcare there are a ton of different use cases for these tests. Some folks are what might be labeled as biohackers. These are the folks that are hard core athletes who want to know whether vitamin D, to their CSRP levels, they want to know exactly where they stand. You can think of these folks as the most proactive and engaged in their health at a biomarker standpoint. And then there’s folks who may be experiencing something that—they’re experiencing some discomfort. Perhaps they’re feeling tired or they’re feeling stressed, and so they hear that there may be a test available to understand where they stand when it comes to, how stressed am I? How tired am I? What does that mean from my healthcare standpoint? Are there things I can do and changes I can make that can improve my health?
And then there’s what’s been called the worried well, and I know that sounds like a negative, but the segment of the patient population is folks who may not have anything wrong with them but they are interested in understanding what they can learn from these tests. It’s an interesting time that we’re in, in terms of direct to consumer testing, so we’re just happy to be a part of it, but also, we really think that what we’re providing as a product and as a service is going to help transition into that next phase of healthcare for consumers. But we’re never going to be a household name. Consumers will never hear about ORDRS, which is ok, we’re ok with that because we’re actually creating a platform by which other startups, like these direct to consumer testing companies, can innovate on top of our platform.
Serafina: So, where are you right now with the company?
Erik: We recently incorporated, and we recently signed our first company. Andwe have a product that is an API at its heart, but it’s also a user interface where a physician can log in and approve an order, where a lab can log in and upload results, where a direct to consumer testing company can log in and see how well they’re doing from a testing standpoint and see where all their tests are. It’s something that quite honestly from a UI perspective, has not existed before.
Serafina: Great point, Erik. That just about wraps up our conversation with Erik Ibarra, CEO of ORDRS.io. Thank you for being with us today.
Erik: Pleasure to be here.
Serafina: And this is The HealthMakers Show.
brought to you by